실험은 250-300g 무게 암컷 흰쥐에서 수행 하였다. 실험실 동물의 관리 및 사용 (실험 동물 자원 연구소, 과학의 국립 아카데미, 베데스다, MD, USA)와 대한 설명서에 명시된 기준을 준수 모든 동물의 절차는 의학 기관 동물 관리의 메이요 클리닉 대학에 의해 승인되었다 및 사용위원회 (IACUC). 1. 준비 <ol><li> 수술 전에 수술 도구를 압력솥. 다른 쥐의 여러 수술이 같은 날에 계획하는 경우, 각 동물 절차 후 악기를 세척하고 뜨거운 비드 살균기를 사용하여 소독. </li><li> 1 L / 분 O 2에서 4 % 이소 플루 란과 쥐를 마취. </li><li> 37 ° C의 체온을 유지하기 위해 조절 된 가열 패드로 쥐를 옮긴다. 1 L / 분 O 2에 1 ~ 2 %의 이소 플루 란으로 마취를 유지한다. </li><li> 진통 약물 (부 프레 놀핀 릴리스 0.6 ㎎ / ㎏을 지속) 스와 관리bcutaneously. </li><li> 절차를 수행하는 동안 건조를 방지하기 위해 눈 연고를 적용합니다. </li><li> 개복에 의한 체액 손실을 보상하기 위해, 수술 전에 0.9 % 생리 식염수를 피하에 10 ㎖ / kg을 투여하는 것이 중요하다. </li><li> 복부 영역을 면도하고 포비돈 - 요오드 및 70 % 에탄올 패드​​로 피부를 청소하십시오. </li></ol> 2. 수술 <ol><li> 진정의 깊이는 발가락 핀치에서 철수, 눈꺼풀 반사, 턱 톤, 호흡 속도 / 패턴으로 물리적 반사 신경을 모니터링하여 적절한 지 확인합니다. </li><li> 수술 용 메스 블레이드 10 호를 사용하여 작은 중간 선 절개를 통해 개복술 (길이 2-2.5 cm)를 수행합니다. </li><li> 면봉을 사용하여 복부의 오른쪽에 소장과 대장을 당겨 기관 촉촉한 유지하기 위해 0.9 % 생리 식염수에 적신 멸균 거즈로 커버. </li><li> 조심스럽게 AOR을 노출 위쪽으로 비장, 간, 위장과 췌장을 철회타 왼쪽 신장 동맥. </li><li> 수술 현미경의 도움으로 조심스럽게 위 왼쪽 신장과 혈관, 지방에서 왼쪽 신장 동맥과 무딘 해부 곡선 집게와 멸균 면봉와 주변의 결합 조직 아래 복부 대동맥을 분리합니다. <ol><li> 지방을 제거하는 측면 회전 운동과 결합 조직과 면봉을 제거하기 위해 선박의 길이를 따라 반복 개폐 동작 (무딘 절개)와 집게를 사용합니다. 참고 : 요정 대동맥 영역의 절개가 손상 될 수 있습니다 신경과 림프관으로 매우 민감한 단계입니다. 해부 과정에서 식염수로 촉촉한 동맥을 유지해야합니다. </li></ol></li><li> 대동맥 아래 4-0 실크 봉합사를 놓습니다. </li><li> 미세 혈관 클립을 사용하여, (그냥 장간막 동맥 이하) 및 신장 동맥 분기 아래에 위의 대동맥 클램프. </li><li> 왼쪽 kidn 수준에서 대동맥 천공24 G 정맥 카테터와 EY 동맥 분기 및 신장 동맥에 카테터를 진행합니다. 참고 :이 발생할 수 있습니다 신장 동맥을 통해 천자 등이 중요한 단계이다. </li><li> 카테터에 약액 또는 (500 μL까지) 식염수로 채워진 주사기를 연결하고 신장 관류. </li><li> 즉시 관류 후, 미세 혈관 클립 왼쪽 신장 정맥 왼쪽 요관을 고정하고 카테터를 제거합니다. 이어서, 대동맥 천공 영역에, 조직 접착제의 작은 방울, 흡수성 지혈제 젤라틴 스폰지 조각을 넣고 부드럽게 면봉으로 압력을 적용한다. </li><li> 동시에, 좌측 신장 동맥의 분기점 아래 복부 대동맥으로부터 클램프 해제. 5 분 후, 신장 혈관 및 요관에서 클램프를 놓습니다. </li><li> 조심스럽게 왼쪽 신장 동맥 분기 이상, 대동맥에서 클램프를 분리 한 신장 재관류를 허용합니다. 총 신 허혈은 7 분보다 더 오래 지속 없습니다. </li><l난&gt; 활성 출혈이 발생하지 않도록 확인하고 밀접하게 10 이상 분의 영역을 관찰합니다. </li><li> 감염을 예방하기 위해 4-0 흡수성 봉합사 및 연속적인 패턴을 사용하여, 두 개의 층 (근육과 피부)의 복부 절개를 닫는다. 연속 패턴 봉합 기술에 더하여, 또 다른 옵션은 열개 않도록 특히 체벽 폐쇄위한 간단한 인터럽트 기술을 사용하는 것이다. </li><li> 감염을 방지하기 위해 절개 영역에 국소 항생제 연고를 적용합니다. </li><li> 35-37 ° C에서 설정된 온도 범위 전체 복구 될 때까지 따뜻한 패드에 침구없는 관찰 케이지에 쥐를 전송합니다. 느슨한 침구 커버 (예 : 드레이프 또는 종이 수건)이나 동물이 완전히 질식 또는 침구의 구토물이기도를 막는 것을 방지하기 위해 복구 될 때까지 케이지에서 제거해야합니다. </li><li> 수술 후 몇 시간 동안 매 시간 후, 자발적으로 호흡 할 때까지 지속적으로 동물을 관찰한다. 진통 부 프레 놀핀 SR 72 시간을 다시 투여 량나중에 불편의 흔적은 같은 웅크 리고 앉게하고 초라한 혼수, 얼굴을 찡 그리기, 정상적인 활동을 재개하지으로 관찰하는 경우. </li><li> 모든 연구 종료 후, CO 2의 과다 복용의 흡입과 동물을 안락사와 생체의 신장 조직은 조직 학적 및 웨스턴 블로 팅 (5)로 분석 수확. </li></ol>

<ol>
	<li>Dejani, H., Eisen, T. D., Finkelstein, F. O. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Revascularization+of+renal+artery+stenosis+in+patients+with+renal+insufficiency.">Revascularization of renal artery stenosis in patients with renal insufficiency.</a> Am. J. Kidney Dis. 36 (4), 752-758 (2000).</li><li>Kang, D. H., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Impaired+angiogenesis+in+the+remnant+kidney+model:+I.+Potential+role+of+vascular+endothelial+growth+factor+and+thrombospondin-1.">Impaired angiogenesis in the remnant kidney model: I. Potential role of vascular endothelial growth factor and thrombospondin-1.</a> J. Am. Soc. Nephrol. 12 (7), 1434-1447 (2001).</li><li>Kang, D. H., Hughes, J., Mazzali, M., Schreiner, G. F., Johnson, R. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Impaired+angiogenesis+in+the+remnant+kidney+model:+II.+Vascular+endothelial+growth+factor+administration+reduces+renal+fibrosis+and+stabilizes+renal+function.">Impaired angiogenesis in the remnant kidney model: II. Vascular endothelial growth factor administration reduces renal fibrosis and stabilizes renal function.</a> J. Am. Soc. Nephrol. 12 (7), 1448-1457 (2001).</li><li>Kang, D. H., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Role+of+the+microvascular+endothelium+in+progressive+renal+disease.">Role of the microvascular endothelium in progressive renal disease.</a> J. Am. Soc. Nephrol. 13 (3), 806-816 (2002).</li><li>Chade, A. R., Kelsen, S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Reversal+of+renal+dysfunction+by+targeted+administration+of+VEGF+into+the+stenotic+kidney:+a+novel+potential+therapeutic+approach.">Reversal of renal dysfunction by targeted administration of VEGF into the stenotic kidney: a novel potential therapeutic approach.</a> Am. J. Physiol.- Renal Physiol. 302 (10), F1342-F1350 (2012).</li><li>Eirin, A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Changes+in+Glomerular+Filtration+Rate+After+Renal+Revascularization+Correlate+With+Microvascular+Hemodynamics+and+Inflammation+in+Swine+Renal+Artery+Stenosis.">Changes in Glomerular Filtration Rate After Renal Revascularization Correlate With Microvascular Hemodynamics and Inflammation in Swine Renal Artery Stenosis.</a> Circ.-Cardiovasc. Interv. 5 (5), 720-728 (2012).</li><li>Chade, A. R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Distinct+Renal+Injury+in+Early+Atherosclerosis+and+Renovascular+Disease.">Distinct Renal Injury in Early Atherosclerosis and Renovascular Disease.</a> Circulation. 106 (9), 1165-1171 (2002).</li><li>Seddon, M., Saw, J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Atherosclerotic+renal+artery+stenosis:+review+of+pathophysiology,+clinical+trial+evidence,+and+management+strategies.">Atherosclerotic renal artery stenosis: review of pathophysiology, clinical trial evidence, and management strategies.</a> Can. J. Cardiol. 27 (4), 468-480 (2011).</li><li>Lao, D., Parasher, P. S., Cho, K. C., Yeghiazarians, Y. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Atherosclerotic+renal+artery+stenosis--diagnosis+and+treatment.">Atherosclerotic renal artery stenosis--diagnosis and treatment.</a> Mayo Clin Proc. 86 (7), 649-657 (2011).</li><li>Sharfuddin, A. A., Molitoris, B. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Pathophysiology+of+ischemic+acute+kidney+injury.">Pathophysiology of ischemic acute kidney injury.</a> Nat. Rev. Nephrol. 7, 189-200 (2011).</li><li>Noiri, E., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Oxidative+and+nitrosative+stress+in+acute+renal+ischemia.">Oxidative and nitrosative stress in acute renal ischemia.</a> Am. J. Physiol.- Renal Physiol. 281 (5), F948-F957 (2001).</li><li>Koesters, R., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Tubular+Overexpression+of+Transforming+Growth+Factor-&#206;1+Induces+Autophagy+and+Fibrosis+but+Not+Mesenchymal+Transition+of+Renal+Epithelial+Cells.">Tubular Overexpression of Transforming Growth Factor-&#206;1 Induces Autophagy and Fibrosis but Not Mesenchymal Transition of Renal Epithelial Cells.</a> Am. J. Pathol. 177 (2), 632-643 (2010).</li><li>Shanley, P. F., Rosen, M. D., Brezis, M., Silva, P., Epstein, F. H., Rosen, S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Topography+of+focal+proximal+tubular+necrosis+after+ischemia+with+reflow+in+the+rat+kidney.">Topography of focal proximal tubular necrosis after ischemia with reflow in the rat kidney.</a> Am. J. Pathol. 122 (3), 462-468 (1986).</li></ol>

이 작품은 부분적으로 아스트라 제네카로부터 연구비에 의해 지원됩니다.

The increasing incidence of chronic kidney disease raises the need for novel therapeutic approaches that can promote functional kidney recovery7,8. Traditional therapies include the systemic administration of anti-inflammatory, anti-fibrotic drugs9. However, these strategies are frequently characterized by unwanted side effects due to off-target distribution of the injected drug. Therefore, in this manuscript, we describe a simple procedure for delivering drugs into the renal artery of rats. This pr...

The renal microvasculature is involved in a wide spectrum of kidney diseases. Depending on the pathophysiology of disease, the endothelial cells may present structural or functional impairment, which may play a pivotal role in propagating kidney damage by creating an ischemic microenvironment. This renal microvascular dysfunction may catalyze the onset of a progressive deterioration of renal function over time, leading to chronic kidney disease (CKD), end-stage renal disease, hypertension and cardiorenal syndrome. In fact, untreated hypertension may have implications in renal arterioles, causing nephrosclerosis or glomerulosclerosis with significant reduction in vascular volume fraction, increase in vascular resistance and development of tubulointerstitial fibrosis1.
Loss of renal microvasculature may be due to altered vascular homeostasis induced by local angiogenic/anti-angiogenic factors imbalance. This correlates with attenuated Vascular Endothelial Growth Factor (VEGF) signaling as well as elevated thrombospondin-12-4. Thus, using different animal models (mice, rats and pigs), the therapeutic effect of exogenous administration of VEGF has been recently investigated in some forms of renal disease, showing reduced interstitial fibrosis and stabilized renal and cardiac function3-5. This effect is likely due to actions of VEGF on endothelial cells of the microvascular bed and inflammatory monocyte phenotype switching6.
For some preclinical studies, the use of rodents, the most commonly used laboratory animals, provides a good animal model for high throughput studies due to relatively low costs and ease of handling. Moreover, the use of genetically-altered rats as models of human diseases, such as hypertension, has become more and more frequent in the scientific community. Therefore, the aim of this protocol is to describe a useful intrarenal VEGF delivery technique in rats that is easy to perform and highly reproducible. Moreover, the same method can be used to selectively deliver other drugs.

<table><tbody><tr><td>Surgical Microscope</td><td>Leica</td><td>M125</td><td></td></tr><tr><td>Isoflurane 100 ml</td><td>Cardinal Healthcare</td><td>PI23238</td><td>Anesthetic</td></tr><tr><td>Buprenorphine HCL SR LAB 1 mg/ml, 5 ml</td><td>ZooPharm Pharmacy</td><td></td><td>Buprenorphine narcotic analgesic formulated in a polymer that slows absorption extending duration of action (72 hr duration of activity).&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; Liquid is viscous, warming to RT aids in drawing into syringe.&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; Recommended dosage: 1 - 1.2 mg/kg SC. DO NOT DILUTE.</td></tr><tr><td>Puralube Vet Ophthalmic Ointment</td><td>Dechra</td><td>NDC17033-211-38</td><td>Sterile ocular lubricant</td></tr><tr><td>Lactated Ringer&#039;s Injection, USP, 250 ml VIAFLEX Plastic Container</td><td>Baxter Healthcare Corp.</td><td>NDC0338-0117-02</td><td>For body fluids replacement</td></tr><tr><td>Sol Povidone-Iodine&amp;nbsp; Swabstick, 3&#039;&amp;nbsp;</td><td>Cardinal Heatlhcare</td><td>23405-010B</td><td></td></tr><tr><td>Sterile cotton tipped applicators</td><td>Kendall</td><td>8884541300</td><td></td></tr><tr><td>4-0 silk suture (without needle)&amp;nbsp;</td><td>Cardinal Heatlhcare</td><td>A183H</td><td></td></tr><tr><td>Vessel Clip, Straight, 0.75 mm x 4 mm Jaw</td><td>World Precision Instruments&amp;nbsp;</td><td>501779-G</td><td></td></tr><tr><td>I.V. Catheter, Straight Hub, Radiopaque, 24 g x 3/4&quot;, FEP Polymer</td><td>Jelco</td><td>4053</td><td></td></tr><tr><td>Phosphate Buffered Saline</td><td>Life Technologies</td><td>10010023</td><td></td></tr><tr><td>SURGIFOAM Absorbable Gelatin Sponge</td><td>Cardinal Healthcare</td><td>179082</td><td></td></tr><tr><td>4-0 VICRYL PLUS (ANTIBACTERIAL) VIOLET 27&quot; RB-1 TAPER</td><td>Ethicon</td><td>VCP304H</td><td>For muscle layer suturing</td></tr><tr><td>4-0 VICRYL PLUS (ANTIBACTERIAL) UNDYED 18&quot; PC-3 CUTTING</td><td>Ethicon</td><td>VCP845G</td><td>For skin layer suturing</td></tr><tr><td>Triple antibiotic ointment</td><td>Actavis</td><td>NDC0472-0179-56</td><td>For topical use on the site of the incision</td></tr><tr><td>Recombinant Rat VEGF 164 Protein</td><td>R&amp;amp;D Sytems</td><td>564-RV</td><td></td></tr><tr><td>Rabbit monoclonal VEGFA</td><td>Abcam</td><td>ab46154</td><td></td></tr><tr><td>Rabbit monoclonal FLK1</td><td>Cell Signaling</td><td>9698</td><td></td></tr><tr><td>Rabbit monoclonal AKT</td><td>Cell Signaling</td><td>4691</td><td></td></tr><tr><td>Rabbit monoclonal phosphoAKT (Ser 473)</td><td>Cell Signaling</td><td>4060</td><td></td></tr><tr><td>Rabbit monoclonal p44/42 MAPK (ERK1/2)</td><td>Cell Signaling</td><td>4695</td><td></td></tr><tr><td>Rabbit monoclonal phospho p44/42 MAPK (Thr202 and Tyr 204)</td><td>Cell Signaling</td><td>4370</td><td></td></tr></tbody></table>

intravascular delivery of biologics to the rat kidney

The renal microvascular compartment plays an important role in the progression of kidney disease and hypertension, leading to the development of End Stage Renal Disease with high risk of death for cardiovascular events. Moreover, recent clinical studies have shown that renovascular structure and function may have a great impact on functional renal recovery after surgery. Here, we describe a protocol for the delivery of drugs into the renal artery of rats. This procedure offers significant advantages over the frequently used systemic administration as it may allow a more localized therapeutic effect. In addition, the use of rodents in pharmacodynamic analysis of preclinical studies may be cost effective, paving the way for the design of translational experiments in larger animal models. Using this technique, infusion of rat recombinant Vascular Endothelial Growth Factor (VEGF) protein in rats has induced activation of VEGF signaling as shown by increased expression of FLK1, pAKT/AKT, pERK/ERK. In summary, we established a protocol for the intrarenal delivery of drugs in rats, which is simple and highly reproducible.

<html> 우리는 재조합 쥐 VEGF (rrVEGF, 0.17 μg의 / kg, 5 μg의 / kg) 또는 PBS의 두 가지 용량을 주입. 동물은 VEGF 경로의 활성을 검사 8 시간 포스트 수술을 안락사시켰다. H &amp; E 염색으로 도시 된 바와 같이, 제어부 (도 1b)에 비해 수술은 관류 신장 (도 1a)의 형태에 영향을 미치지 않았다. 제어 (그림 1D)에 비해 시리우스 레드 염색은...

Watch this Scientific Journal Video about Intravascular Delivery of Biologics to the Rat Kidney at JoVE.com

Intravascular Delivery of Biologics to the Rat Kidney

신장 기능의 회복을위한 약물의 투여는 현지화 및 치료 화합물의 분포 컨트롤이 필요합니다. 여기, 우리는 구체적으로 쥐에 약물의 신장 내 전달을위한 간단한 방법을 설명합니다. 이 절차는 쉽고없이 사망률과 높은 재현성으로 수행 될 수있다.

쥐의 신장에 생물의 혈관 배달

The renal microvascular compartment plays an important role in the progression of kidney disease and hypertension, leading to the development of End Stage ...

intravascular-delivery-of-biologics-to-the-rat-kidney

Research

JoVE Journal

Medicine

7.5K 조회수.  Mayo Clinic.  신장 기능의 회복을위한 약물의 투여는 현지화 및 치료 화합물의 분포 컨트롤이 필요합니다. 여기, 우리는 구체적으로 쥐에 약물의 신장 내 전달을위한 간단한 방법을 설명합니다. 이 절차는 쉽고없이 사망률과 높은 재현성으로 수행 될 수있다. 

비디오: Intravascular Delivery of Biologics to the Rat Kidney

Setting-up an In Vitro Model of Rat Blood-brain Barrier (BBB): A Focus on BBB Impermeability and Receptor-mediated Transport

The blood brain barrier (BBB) specifically regulates molecular and cellular flux between the blood and the nervous tissue. Our aim was to develop and characterize a highly reproducible rat syngeneic in vitro model of the BBB using co-cultures of primary rat brain endothelial cells (RBEC) and astrocytes to study receptors involved in transcytosis across the endothelial cell monolayer. Astrocytes were isolated by mechanical dissection following trypsin digestion and were frozen for later co-culture. RBEC were isolated from 5-week-old rat cortices. The brains were cleaned of meninges and white matter, and mechanically dissociated following enzymatic digestion. Thereafter, the tissue homogenate was centrifuged in bovine serum albumin to separate vessel fragments from nervous tissue. The vessel fragments underwent a second enzymatic digestion to free endothelial cells from their extracellular matrix. The remaining contaminating cells such as pericytes were further eliminated by plating the microvessel fragments in puromycin-containing medium. They were then passaged onto filters for co-culture with astrocytes grown on the bottom of the wells. RBEC expressed high levels of tight junction (TJ) proteins such as occludin, claudin-5 and ZO-1 with a typical localization at the cell borders. The transendothelial electrical resistance (TEER) of brain endothelial monolayers, indicating the tightness of TJs reached 300 ohm&#183;cm2 on average. The endothelial permeability coefficients (Pe) for lucifer yellow (LY) was highly reproducible with an average of 0.26 &#177;&#160;0.11 x 10-3 cm/min. Brain endothelial cells organized in monolayers expressed the efflux transporter P-glycoprotein (P-gp), showed a polarized transport of rhodamine 123, a ligand for P-gp, and showed specific transport of transferrin-Cy3 and DiILDL across the endothelial cell monolayer. In conclusion, we provide a protocol for setting up an in vitro BBB model that is highly reproducible due to the quality assurance methods, and that is suitable for research on BBB transporters and receptors.

Setting-up an In Vitro Model of Rat Blood-brain Barrier BBB: A Focus on BBB Impermeability and Receptor-mediated Transport

The aim of the present study was to validate the reproducibility of an in vitro BBB model involving a rat syngeneic co-culture of endothelial cells and astrocytes. The endothelial cell monolayer presented high TEER and low LY permeability. Expression of specific TJ proteins, functional responses to inflammation and functionality of transporters and receptors were assessed.

설정 - 업<em&gt; 체외</em쥐 뇌 혈관 벽의&gt; 모델 (BBB)​​ : BBB 불 침투성 및 수용체 매개 운송에 초점

The blood brain barrier (BBB) specifically regulates molecular and cellular flux between the blood and the nervous tissue. Our aim was to develop and ...

연구

의학

Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats

Hepatocellular carcinoma (HCC) is a disease with limited treatment options and poor prognosis. In recent years, oncolytic virotherapies have proven themselves to be potentially powerful tools to fight malignancy. Due to the unique dual blood supply in the liver, it is possible to apply therapies locally to orthotopic liver tumors, which are predominantly fed by arterial blood flow. We have previously demonstrated that hepatic arterial delivery of oncolytic viruses results in safe and efficient transduction efficiency of multifocal HCC lesions, resulting in significant prolongation of survival in immune competent rats. This procedure closely mimics the application of transarterial embolization in patients, which is the standard palliative care provided to many HCC patients. The ability to administer tumor therapies through the hepatic artery in rats allows for a highly sophisticated preclinical model for evaluating novel viral vectors under development. Here we describe the detailed protocol for microdissection of the hepatic artery for infusion of oncolytic virus vectors to treat orthotopic HCC.

Oncolytic virotherapies are under development as novel therapeutics for the treatment of hepatocellular carcinoma (HCC). Here we describe a method for locoregional therapy of HCC via hepatic arterial administration of oncolytic virus.

쥐에서 동소 이식 간세포 암의 국소 치료에 대한 종양 살상 바이러스의 간동맥 관리

Hepatocellular carcinoma (HCC) is a disease with limited treatment options and poor prognosis.  In recent years, oncolytic virotherapies have proven ...

Intraluminal Drug Delivery to the Mouse Arteriovenous Fistula Endothelium

Delivery of therapeutic agents to enhance arteriovenous fistula (AVF) maturation can be administered either via intraluminal or external routes. The simple murine AVF model was combined with intraluminal administration of drug solution to the venous endothelium at the same time as fistula creation. Technical aspects of this model are discussed. Under general anesthesia, an abdominal incision is made and the aorta and inferior vena cava (IVC) are exposed. The infra-renal aorta and IVC are dissected for clamping. After proximal and distal clamping, the puncture site is exposed and a 25 G needle is used to puncture both walls of the aorta and into the IVC. Immediately after the puncture, a reporter gene-expressing viral vector was infused in the IVC via the same needle, followed by 15 min of incubation. The intraluminal administration method enabled more robust viral gene delivery to the venous endothelium compared to administration by the external route. This novel method of delivery will facilitate studies that explore the role of the endothelium in AVF maturation and enable intraluminal drug delivery at the time of surgical operation.

After puncturing the aorta through the inferior vena cava (IVC) to create an aorto-caval fistula in the mouse, solution containing a drug is infused into the IVC via the same needle, followed by incubation. This method enables more robust drug delivery to the venous endothelium compared to the external route.

마우스 동정맥루 내피에 관내 약물 전달

Delivery of therapeutic agents to enhance arteriovenous fistula (AVF) maturation can be administered either via intraluminal or external routes. The ...

Orthotopic Rat Kidney Transplantation: A Novel and Simplified Surgical Approach

Kidney transplantation offers increased survival rates and improved quality of life for patients with end-stage renal disease, as compared to any type of renal replacement therapy. Over the past few decades, the rat kidney transplantation model has been used to study the immunological phenomena of rejection and tolerance. This model has become an indispensable tool to test new immunomodulatory pharmaceuticals and regimens prior to proceeding with expensive preclinical large animal studies.
This protocol provides a detailed overview of how to reliably perform orthotopic kidney transplantation in rats. This protocol includes three distinctive steps that increase the probability of success: perfusion of the donor kidney by flushing through the portal vein and the use of a cuff system to anastomose the renal veins and ureters, thereby decreasing cold and warm ischemia times. Using this technique, we have achieved survival rates beyond 6 months with normal serum creatinine in animals with syngeneic or tolerant kidney transplants. Depending on the aim of the study, this model can be modified by pre- or posttransplant treatments to study the acute, chronic, cellular, or antibody-mediated rejection. It is a reproducible, reliable, and cost-effective animal model to study different aspects of kidney transplantation.

The purpose of this manuscript and protocol is to explain and demonstrate in detail the surgical procedure of orthotopic kidney transplantation in rats. This method is simplified to achieve the correct perfusion of the donor kidney and shorten the reperfusion time by using the venous and ureteral cuff anastomosis technique.

직교 쥐 신장 이식: 새롭고 단순화 된 외과 접근

Kidney transplantation offers increased survival rates and improved quality of life for patients with end-stage renal disease, as compared to any type of ...

Intraventricular Drug Delivery and Sampling for Pharmacokinetics and Pharmacodynamics Study

Although the blood-brain barrier (BBB) protects the brain from foreign entities, it also prevents some therapeutics from crossing into the central nervous system (CNS) to ameliorate diseases or infections. Drugs are administered directly into the CNS in animals and humans to circumvent the BBB. The present protocol describes a unique way of treating brain infections through intraventricular delivery of antibiotics, i.e., polymyxins, the last-line antibiotics to treat multi-drug resistant Gram-negative bacteria. A straightforward stereotaxic surgery protocol was developed to implant a guide cannula reaching into the lateral ventricle in rats. After a recovery period of 24 h, rats can be injected consciously and repeatedly through a cannula that is fitted to the guide. Injections can be delivered manually as a bolus or infusion using a microinjection pump to obtain a slow and controlled flow rate. The intraventricular injection was successfully confirmed with Evans Blue dye. Cerebrospinal fluid (CSF) can be drained, and the brain and other organs can be collected. This approach is highly amenable for studies involving drug delivery to the CNS and subsequent assessment of pharmacokinetic and pharmacodynamic activity.

<meta charset="utf8"></head><body>약동학 및 약력학 연구를 위한 뇌실 내 약물 전달 및 샘플링

Delivery of therapeutics directly into the central nervous system is one way of circumventing the blood-brain barrier. The present protocol demonstrates intracerebroventricular injection for subsequent collection of cerebrospinal fluid and bodily organs. This facilitates the investigation of drug pharmacokinetics and pharmacodynamics in animal models for developing new treatments.

약동학 및 약력학 연구를 위한 뇌실 내 약물 전달 및 샘플링

Although the blood-brain barrier (BBB) protects the brain from foreign entities, it also prevents some therapeutics from crossing into the central nervous ...

신경과학

Direct Drug Delivery to Kidney via the Renal Artery

There is a need for directed injections to enable increased and specific renal exposure for efficient evaluation of drug targets in the renal research field. Accumulation of drugs in certain organs may give rise to adverse and unwanted effects, depending on the nature of injectate. To minimize spillover and/or accumulation in other tissues, the herein described method directs the formulation into the renal artery bloodstream by inserting a catheter in the infra renal aorta, just below where it branches into the renal artery, resulting in the kidney as first reached organ and distributing of formulation throughout the kidney.
This manuscript provides a detailed description of the method, as well as its challenges and difficulties. It guides the experimenter to become skillful with this type of microsurgery that requires accuracy under sterile conditions. Speed is crucial for minimizing the ischemia and practicing the procedure will increase the chance of successful injections without adverse effects. By modulating the time between injection and reperfusion as well as the injected volume, the risk of spillover to other organs is mitigated. 
Note that this technique is suitable for single dosing strategies.

This manuscript describes a method for targeted delivery to a single kidney via a catheter placed in the infrarenal abdominal aorta in the mouse.

신장 동맥을 통해 신장에 직접 약물 전달

There is a need for directed injections to enable increased and specific renal exposure for efficient evaluation of drug targets in the renal research ...

A Rat Orthotopic Renal Transplantation Model for Renal Allograft Rejection

Renal allograft rejection limits the long-term survival of patients after renal transplantation. Rat orthotopic renal transplantation is an essential model to investigate the mechanism of renal allograft rejection in pre-clinical studies and could aid in the development of novel approaches to improve the long-term survival of renal allografts. Donor kidney implantation in rat orthotopic renal transplantation is commonly performed by end-to-side anastomosis to recipients' aorta and inferior vena cava. In this model, the donor's kidney was implanted using end-to-end anastomosis to the recipients' renal artery and renal vein. The donor's ureter was anastomosed to the recipient's bladder in an end-to-side 'tunnel' method. This model contributes to better healing of ureter-bladder anastomosis and increases the recipients' survival by avoiding interference with blood supply and venous reflux of the lower body. This model can be used to investigate the mechanisms of acute and chronic immune and pathologic rejection of renal allografts. Here, the study describes the detailed protocols of this orthotopic renal transplantation between rats.

The rat orthotopic renal transplantation model contributes to investigating the mechanism of renal allograft rejection. The current model increases the recipients' survival without interference with blood supply and venous reflux of the lower body using an end-to-end anastomosis of kidney implantation and an end-to-side "tunnel" method of ureter-bladder anastomosis.

신장 동종이식편 거부반응을 위한 쥐 동위원소 신장 이식 모델

Renal allograft rejection limits the long-term survival of patients after renal transplantation. Rat orthotopic renal transplantation is an essential ...

Hydrodynamic Renal Pelvis Injection for Non-viral Expression of Proteins in the Kidney

Hydrodynamic injection creates a local, high-pressure environment to transfect various tissues with plasmid DNA and other substances. Hydrodynamic tail vein injection, for example, is a well-established method by which the liver can be transfected. This manuscript describes an application of hydrodynamic principles by injection of the mouse kidney directly with plasmid DNA for kidney-specific gene expression. Mice are anesthetized and the kidney is exposed by a flank incision followed by a fast injection of a plasmid DNA-containing solution directly into the renal pelvis. The needle is kept in place for ten seconds and the incision site is sutured. The following day, live animal imaging, Western blot, or immunohistochemistry may be used to assay gene expression, or other assays suited to the transgene of choice are used for detection of the protein of interest. Published methods to prolong gene expression include transposon-mediated transgene integration and cyclophosphamide treatment to inhibit the immune response to the transgene.

This protocol describes a method to inject plasmid DNA into the mouse kidney via the renal pelvis to produce transgene expression specifically in the kidney.

유체역학 신장 골반 주입은 신장에서 단백질의 비 바이러스 성 표현에 대 한

Hydrodynamic injection creates a local, high-pressure environment to transfect various tissues with plasmid DNA and other substances. Hydrodynamic tail ...

생물학

Hydrodynamic Renal Pelvis Injection: A Technique to Directly Deliver DNA into Kidney Cells of Murine Model

Source: Woodard, L. E. et al. <a href="https://www.jove.com/video/56324" target="_blank">Hydrodynamic Renal Pelvis Injection for Non-viral Expression of Proteins in the Kidney.</a> J. Vis. Exp. (2018)
In this video, we present the protocol for hydrodynamic injection of plasmids into the renal pelvis of the mouse kidney for nucleic acid transfection. This technique allows organ-specific delivery of plasmids by utilizing the principle of high hydrostatic pressure, which forcefully drives the plasmids into the specific site without causing tissue injury.

유체역학적 신장 골반 주사: 쥐 모델의 신장 세포에 DNA를 직접 전달하는 기술

Source: Woodard, L. E. et al. Hydrodynamic Renal Pelvis Injection for Non-viral Expression of Proteins in the Kidney. J. Vis. Exp. (2018)
In this video, ...

쥐의 신장에 생물의 혈관 배달

요약

더 많은 비디오 탐색

이 비디오의 챕터

설정 - 업

쥐에서 동소 이식 간세포 암의 국소 치료에 대한 종양 살상 바이러스의 간동맥 관리

마우스 동정맥루 내피에 관내 약물 전달

직교 쥐 신장 이식: 새롭고 단순화 된 외과 접근

약동학 및 약력학 연구를 위한 뇌실 내 약물 전달 및 샘플링

약동학 및 약력학 연구를 위한 뇌실 내 약물 전달 및 샘플링

신장 동맥을 통해 신장에 직접 약물 전달

신장 동종이식편 거부반응을 위한 쥐 동위원소 신장 이식 모델

유체역학 신장 골반 주입은 신장에서 단백질의 비 바이러스 성 표현에 대 한

유체역학적 신장 골반 주사: 쥐 모델의 신장 세포에 DNA를 직접 전달하는 기술